Newsletter

End-Stage Renal Disease
Most Anticipated Emerging Drugs in the ESRD Domain Cause a Positive Paradigm Shift in the Market
End-Stage Renal Disease Newsletter

More Whitepapers / Newsletters

Schizophrenia Market
Schizophrenia

Schizophrenia is a severe mental illness that interferes with a person's ability to think clearly, manage emotions, make decisions, and relate to others. It is a complex, long-term medical illness, af...
An Abundance Of Rare Newsletter
An Abundance Of Rare

Though appear rare, rare diseases are far from being rare. With over 7,000 rare disease affecting millions worldwide, Rare disease pose a huge burden on the global healthcare system, affecting the qua...
Exocrine Pancreatic Insufficiency
Exocrine Pancreatic Insufficie...

A degenerative disease, Exocrine Pancreatic Insufficiency (EPI), is a consequence of insufficient production and secretion of pancreatic digestive enzymes, which leads to maldigestion in the duodenum....
Consumer Healthcare during COVID-19
The Changing face of Consumer...

With worldwide dissemination and now over 9 million cases and nearly 500,000 deaths recorded, the effect of COVID-19 has been far-reaching and unpredictable. As people remain aware of new cases and de...
Lyme Disease Market
Lyme Disease

Lyme disease is a vector-borne infectious disease that spreads primarily by the bite of a tick (also known as Ixodes scapularis). It is quite a common disease, and poses a huge economic burden to glob...